Boston, MA 04/17/2014 (wallstreetpr) – Natural products provider, Chromadex Corp (OTCMKTS:CDXC), has entered into a material transfer agreement with Novo Nordosik Foundation, at the University Of Copenhagen, Denmark. Part of the deal will involve the company providing the university with quantities of its NIAGEN, to be used for research. NIAGEN is a patented form of NR […]
